FINDEX : Notice of partial corrections to the Consolidated Financial Results

	August 9, 2022
Company:	FINDEX Inc
Representative:	Teruo Aibara, President & CEO
	(Stock code: 3649, TSE Prime)
Contact:	Atsushi Fujita
	Director and Head of Administration
	(TEL: [phone])

[Correction] Notice of partial corrections

to the Consolidated Financial Results [Japanese GAAP]

for the First Quarter of the Fiscal Year Ending December 31, 2022

We have found that corrections are required to certain items stated in the Consolidated Financial Results [Japanese GAAP] for the First Quarter of the Fiscal Year Ending December 31, 2022, which was disclosed on May 12th, 2022. The followings below are details of corrections.

1. Reason for corrections

After having filed the Consolidated Financial Results [Japanese GAAP] for the First Quarter of the Fiscal Year Ending December 31, 2022, we discovered partial error in stated items. This notice is retrospectively to correct those items.

2. Items to be corrected

Items to be retrospectively corrected are underlined as below.

[Before correction]

2. Quarterly Financial Statements and Notes

1. Notes to Quarterly Consolidated Financial Statement (Revenue Recognition)
   The Group's revenues are primarily derived from revenues recognized from contracts with customers, and the following information breaks down the Group's reportable segments by the timing of revenue recognition and types of services.

FY 2022 1Q (From January 1, 2022, to March 31, 2022)

（JPY in Thousands）

		Reportable segment	Total
		System development	Healthtech
Timing of revenue recognition
Revenue recognized at a point	861,224	43,397	904,622
in time
Revenue recognized over	a	359,953	-	359,953
period of time
Total		1,221,178	43,397	1,264,576

[After correction]

2. Quarterly Financial Statements and Notes

1. Notes to Quarterly Consolidated Financial Statement

(Revenue Recognition)

The Group's revenues are primarily derived from revenues recognized from contracts with customers, and the following information breaks down the Group's reportable segments by the timing of revenue recognition and types of services.

FY 2022 1Q (From January 1, 2022, to March 31, 2022)

（JPY in Thousands）

		Reportable segment	Total
		System development	Healthtech
Timing of revenue recognition
Revenue recognized at a point	598,682	43,397	642,080
in time
Revenue recognized over	a	622,495	-	622,495
period of time
Total		1,221,178	43,397	1,264,576